Donald Allen Williams - 10 Jun 2026 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
12 Jun 2026, 20:12:31 UTC
Prior SEC filing
21 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ryker Willie, Attorney-in-Fact for Donald Allen Williams

Key filing fact

Donald Allen Williams filed Form 4 for PALISADE BIO, INC. (PALI) on 12 Jun 2026.

Key facts

  • This page summarizes Donald Allen Williams's Form 4 filing for PALISADE BIO, INC. (PALI).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 12 Jun 2026, 20:12.

Change

  • Previous filing in this sequence was filed on 21 Jan 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001620013 Primary reporting owner

Williams Donald Allen

Relationship
Director
Address
C/O PALISADE BIO, INC., 4600 SOUTH SYRACUSE STREET, SUITE 900, DENVER
Signature
/s/ Ryker Willie, Attorney-in-Fact for Donald Allen Williams
Signature date
12 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PALI transaction

Common Stock

Award

Transaction value
Shares
+1,498,900
Change %
+13972%
Price
Shares after
1,509,628
Date
10 Jun 2026
Ownership
Direct
Footnotes
F1
PALI transaction

Common Stock

Options Exercise

Transaction value
Shares
+60,666
Change %
+4%
Price
Shares after
1,570,294
Date
10 Jun 2026
Ownership
Direct
Footnotes
F2
PALI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,000
Date
10 Jun 2026
Ownership
By Reporting Person's Defined Benefit Plan

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PALI transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-60,666
Change %
-33%
Price
$0.000000*
Shares after
121,334
Date
10 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
60,666
Exercise price
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2027 annual meeting of stockholders or (ii) the anniversary of June 10, 2026, subject to the Reporting Person's continuous service with the Issuer through such date.

Footnote F2

The Reporting Person was granted RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested on June 10, 2026.

Footnote F3

The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .